Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent
Patent
1986-12-08
1989-08-22
Warden, Robert J.
Drug, bio-affecting and body treating compositions
In vivo diagnosis or in vivo testing
Magnetic imaging agent
424 4, 424 858, 128653, 128654, A61K 4900, A61B 505, A61B 600
Patent
active
048594504
ABSTRACT:
An in vivo NMR imaging method comprising administering to a human patient an NMR contrast agent comprising a specific affinity organic substituent complexed with a paramagnetic substance and subjecting the patient to NMR imaging.
REFERENCES:
patent: 4352751 (1982-10-01), Wieder et al.
patent: 4454106 (1984-06-01), Ganson et al.
patent: 4647447 (1987-03-01), Gries et al.
Lauterbur et al., Frontiers of Biological Energetics, vol. 1 (1978), pp. 752-759.
Unger et al., "Magnetic Resonance Imaging Using Gadolinium Labeled Monoclonal Antibody", Investigative Radiology, vol. 20, Oct. 1985, pp. 693-700.
The General Hospital Corporation
Warden Robert J.
Wieder Stephen C.
LandOfFree
Method of NMR imaging using antibody to cardiac myosin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of NMR imaging using antibody to cardiac myosin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of NMR imaging using antibody to cardiac myosin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2416852